Cartesian Therapeutics Inc (RNAC)
26.41
+0.07
(+0.27%)
USD |
NASDAQ |
May 17, 16:00
26.41
0.00 (0.00%)
After-Hours: 20:00
Cartesian Therapeutics 1 Year Total Returns (Daily): -20.63% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -20.63% |
May 16, 2024 | -19.08% |
May 15, 2024 | -23.42% |
May 14, 2024 | -28.88% |
May 13, 2024 | -38.36% |
May 10, 2024 | -42.63% |
May 09, 2024 | -38.25% |
May 08, 2024 | -34.87% |
May 07, 2024 | -28.38% |
May 06, 2024 | -20.56% |
May 03, 2024 | -25.80% |
May 02, 2024 | -28.57% |
May 01, 2024 | -33.22% |
April 30, 2024 | -38.18% |
April 29, 2024 | -38.38% |
April 26, 2024 | -40.09% |
April 25, 2024 | -33.01% |
April 24, 2024 | -37.78% |
April 23, 2024 | -38.17% |
April 22, 2024 | -45.17% |
April 19, 2024 | -51.46% |
April 18, 2024 | -52.79% |
April 17, 2024 | -50.47% |
April 16, 2024 | -48.29% |
April 15, 2024 | -47.69% |
Date | Value |
---|---|
April 12, 2024 | -44.28% |
April 11, 2024 | -54.10% |
April 10, 2024 | -57.83% |
April 09, 2024 | -64.40% |
April 08, 2024 | -66.62% |
April 05, 2024 | -65.87% |
April 04, 2024 | -61.52% |
April 03, 2024 | -64.23% |
April 02, 2024 | -61.86% |
April 01, 2024 | -59.70% |
March 28, 2024 | -49.22% |
March 27, 2024 | -50.35% |
March 26, 2024 | -55.73% |
March 25, 2024 | -51.77% |
March 22, 2024 | -49.35% |
March 21, 2024 | -44.14% |
March 20, 2024 | -39.90% |
March 19, 2024 | -46.73% |
March 18, 2024 | -53.19% |
March 15, 2024 | -58.55% |
March 14, 2024 | -63.34% |
March 13, 2024 | -61.81% |
March 12, 2024 | -57.07% |
March 11, 2024 | -53.36% |
March 08, 2024 | -58.71% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-90.85%
Minimum
Oct 17 2019
192.7%
Maximum
Mar 18 2021
-9.12%
Average
-23.11%
Median
Feb 08 2023
1 Year Total Returns (Daily) Benchmarks
Marinus Pharmaceuticals Inc | -84.00% |
Adial Pharmaceuticals Inc | -81.44% |
Poseida Therapeutics Inc | 18.15% |
Biomea Fusion Inc | -62.78% |
NovaBay Pharmaceuticals Inc | -83.53% |